Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
The American Journal of Psychiatry
|
September 1, 1997
Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol
G D Tollefson, C M Beasley, R N Tamura, et al.
Bulletin of the Los Angeles Neurological Societies
|
January 1, 1982
Multimodality evoked potentials: clinical applications and assessment of utility
S N Cohen, A Potvin, K Syndulko, et al.
The International Journal of Neuroscience
|
January 1, 1981
Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients
K Syndulko, E R Gilden, E C Hansch, et al.
Archives of Neurology
|
March 1, 1983
Multimodality evoked potentials and neurophysiological tests in multiple sclerosis. Effects of hyperthermia on test results
K R Phillips, A R Potvin, K Syndulko, et al.
The Journal of Clinical Psychiatry
|
May 1, 1997
Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia
P V Tran, M A Dellva, G D Tollefson, et al.
Obesity Research
|
March 1, 1993
Fluoxetine: a randomized clinical trial in the maintenance of weight loss
D J Goldstein, A H Rampey, B E Dornseif, et al.
Journal of Affective Disorders
|
January 11, 1992
Fluoxetine: no association with suicidality in obsessive-compulsive disorder
C M Beasley, J H Potvin, D N Masica, et al.
The Journal of Clinical Psychiatry
|
July 11, 1992
Lack of association between fluoxetine and suicidality in bulimia nervosa
D E Wheadon, A H Rampey, V L Thompson, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
March 1, 1994
Fluoxetine: a randomized clinical trial in the treatment of obesity
D J Goldstein, A H Rampey, G G Enas, et al.
Neurology
|
November 1, 1980
Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids
W W Tourtellotte, R W Baumhefner, A R Potvin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
The American Journal of Psychiatry
|
September 1, 1997
Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol
G D Tollefson, C M Beasley, R N Tamura, et al.
Bulletin of the Los Angeles Neurological Societies
|
January 1, 1982
Multimodality evoked potentials: clinical applications and assessment of utility
S N Cohen, A Potvin, K Syndulko, et al.
The International Journal of Neuroscience
|
January 1, 1981
Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients
K Syndulko, E R Gilden, E C Hansch, et al.
Archives of Neurology
|
March 1, 1983
Multimodality evoked potentials and neurophysiological tests in multiple sclerosis. Effects of hyperthermia on test results
K R Phillips, A R Potvin, K Syndulko, et al.
The Journal of Clinical Psychiatry
|
May 1, 1997
Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia
P V Tran, M A Dellva, G D Tollefson, et al.
Obesity Research
|
March 1, 1993
Fluoxetine: a randomized clinical trial in the maintenance of weight loss
D J Goldstein, A H Rampey, B E Dornseif, et al.
Journal of Affective Disorders
|
January 11, 1992
Fluoxetine: no association with suicidality in obsessive-compulsive disorder
C M Beasley, J H Potvin, D N Masica, et al.
The Journal of Clinical Psychiatry
|
July 11, 1992
Lack of association between fluoxetine and suicidality in bulimia nervosa
D E Wheadon, A H Rampey, V L Thompson, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
March 1, 1994
Fluoxetine: a randomized clinical trial in the treatment of obesity
D J Goldstein, A H Rampey, G G Enas, et al.
Neurology
|
November 1, 1980
Multiple sclerosis de novo CNS IgG synthesis: effect of ACTH and corticosteroids
W W Tourtellotte, R W Baumhefner, A R Potvin, et al.
Page
of 4